Pfizer Inc.
Boron Containing PDE4 Inhibitors
Last updated:
Abstract:
The present invention relates to boron containing compounds of Formula (I) X--Y--Z Formula (I) that inhibit phosphodiesterase 4 (PDE4). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders ameliorated by inhibition of PDE4.
Status:
Application
Type:
Utility
Filling date:
28 Oct 2020
Issue date:
11 Mar 2021